Clinical Trial Update: Targeted Busulfan, Fludarabine Conditioning Regimen for Hematopoietic Stem Cell Transplantation in GRD [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating a targeted busulfan and fludarabine conditioning regimen for hematopoietic stem cell transplantation in genetic rare disease patien…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Genetic Rare Disease

Drugs mentioned

• BUSULFAN (Busulfan)
• Fludarabine (Fludarabine)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Genetic Rare Disease | Phase 1, Phase 2 | Status: UNKNOWN